Alok Sonig | Association for Accessible Medicines
AAM All Access Podcast - Dan Leonard speaks to David Gaugh (AAM), Jessica Daley (Premier Inc) and Steven Schondelmeyer (University of Minnesota).

Alok Sonig

CEO, US Generics and Global Head - Generics R&D & Biosimilars, Lupin Pharmaceuticals, Inc.
Alok Sonig
Alok Sonig
Lupin Pharmaceuticals, Inc.

Alok (Pron: Ah-Loke) Sonig is CEO, US Generics and Global Head, Generics R&D and Biosimilars of Lupin, Inc. ​

With over 23 years of experience in the pharmaceutical industry, Alok has previously served as the CEO of Developed Markets (U.S., Canada, Europe and Japan) at Dr. Reddy's Laboratories. Prior to Dr. Reddy's Laboratories, he spent over 15 years at Bristol-Myers Squibb, where he held several positions of increasing responsibilities in General Management, Global Strategy, and Marketing. ​

Alok holds a Bachelor's of Engineering from Punjab Engineering College in India and an MBA from American University in Washington, DC. ​

Latest Tweets

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.